GB
Gil Blum Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
107
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $10 |
119%
upside
| 1 | +28% |
0
%
| 3 Mar ‘26 3 days ago |
|
|
|
Buy
Maintained
| $75 |
128%
upside
| 1 | +5.8% |
0
%
| 26 Feb ‘26 8 days ago |
|
|
|
Buy
Reiterated
| $8 |
131%
upside
| 1 | -3.2% |
0
%
| 26 Feb ‘26 8 days ago |
|
|
|
Hold
Downgraded
| – | – | 3 | -3.9% |
0
%
| 23 Feb ‘26 11 days ago |
|
|
|
Buy
Maintained
| $82 |
45%
upside
| 2 | +8.7% |
0
%
| 13 Feb ‘26 21 days ago |
|
|
|
Buy
Reiterated
| $16 |
137%
upside
| 2 | +9.8% |
0
%
| 9 Feb ‘26 25 days ago |
|
|
|
Buy
Reiterated
| $26 |
72%
upside
| 2 | +9% |
0
%
| 29 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $3 |
661%
upside
| 2 | -17% |
0
%
| 13 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $10 |
562%
upside
| 3 | +6.9% |
0
%
| 12 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $42 |
513%
upside
| 1 | -19% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Hold
Downgraded
| – | – | 1 | +37% |
0
%
| 19 Dec ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $7 |
194%
upside
| 1 | -1% |
0
%
| 12 Dec ‘25 2 months ago |
|